measuregroup/AID1795619

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID378162161_AID1795619_PMID_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID378162165_AID1795619_PMID_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID378162168_AID1795619_PMID_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID378162163_AID1795619_PMID_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID378162166_AID1795619_PMID_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID378162155_AID1795619_PMID_VALUE1
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ12809
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	hERG Channel Inhibition from US Patent US10030026: \"Difluoroethylpyridine derivatives as NR2B NMDA receptor antagonists\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID378162165 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID378162163 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID378162155 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID378162161 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID378162168 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID378162166
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1795619

Total number of triples: 17.